鹏华医药科技股票C(017900)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
1,915,561.21 |
3,939,688.87 |
149,141.77 |
252,285.79 |
| 存出保证金 |
949,648.29 |
1,805,542.37 |
343,148.05 |
140,637.37 |
| 交易性金融资产 |
2,043,663,623.87 |
3,040,929,499.01 |
2,421,661,505.45 |
2,402,437,457.19 |
| 其中:股票投资 |
2,043,663,623.87 |
3,040,929,499.01 |
2,421,661,505.45 |
2,402,437,457.19 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
52,874,218.92 |
- |
- |
43,118.19 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
10,107,838.88 |
12,036,195.32 |
18,548,744.42 |
1,852,263.55 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
2,609,986,908.10 |
3,848,453,708.87 |
2,685,138,532.25 |
2,685,293,918.30 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
3,785,355.06 |
12,932,537.84 |
- |
| 应付赎回款 |
79,041,934.80 |
46,847,078.25 |
67,419,093.06 |
127,559,452.74 |
| 应付管理人报酬 |
2,560,612.72 |
3,762,943.39 |
2,693,091.59 |
2,915,235.30 |
| 应付托管费 |
426,768.80 |
627,157.23 |
448,848.61 |
485,872.56 |
| 应付销售服务费 |
392,147.13 |
662,943.84 |
223,471.59 |
188,233.30 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
1,003,674.00 |
1,155,305.00 |
563,360.47 |
412,660.48 |
| 负债合计 |
83,425,137.45 |
56,840,782.77 |
84,280,403.16 |
131,561,454.38 |
| 所有者权益 |
| 实收基金 |
1,742,681,903.43 |
2,473,801,024.44 |
1,764,862,597.61 |
2,608,393,419.90 |
| 未分配利润 |
783,879,867.22 |
1,317,811,901.66 |
835,995,531.48 |
-54,660,955.98 |
| 所有者权益合计 |
2,526,561,770.65 |
3,791,612,926.10 |
2,600,858,129.09 |
2,553,732,463.92 |
| 负债及所有者权益总计 |
2,609,986,908.10 |
3,848,453,708.87 |
2,685,138,532.25 |
2,685,293,918.30 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年